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Abstract The binding of BPTI and SBTI with trypsin has been 
investigated by ESI MS, using the mutant K15V-BPTI and the 
chemically modified RcamBPTI as controls. Although high cone 
voltages (+80 V) produce sharp spectra of BPTI, RcamBPTI, 
SBTI and trypsin alone, the complexes of BPTI, RcamBPTI and 
SBTI with trypsin undergo partial dissociation due to collisional 
activation. At lower cone voltages (+40 V) these non-covalent 
complexes are stable. The charge distribution on the trypsin and 
the inhibitors produced by gas phase dissociation of the 
complexes are markedly different from those of the components 
alone, indicating that ESI MS provides a novel probe for 
exploring the ionic interactions at the contact surface of proteins. 
Moreover, by determining the cone voltage at which the gas 
phase dissociation of complexes occurs it may be possible to use 
ESI MS to compare the binding energies of closely related 
complexes. 
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1. Introduction 
ESI MS is rapidly becoming a routine technique for the 
observation of non-covalent protein-small molecule and pro- 
tein-protein complexes. Conditions have now been developed 
such that spectra can be obtained from picomole quantities of 
protein in their native conformations. The solvents are essen- 
tially at physiological pH and the source temperature is 40°C 
or below. This not only avoids the denaturing conditions that 
have been used previously, but also allows the study of pro- 
teins under conditions in which they can be detected as com- 
plexes with substrates, products or inhibitors. Initially, ESI 
MS was restricted to the study of complexes in which the 
ligand (substrate or product) was covalently bound [1], but 
increasingly non-covalently bound enzyme complexes are 
being studied [2-5]. However, these studies have principally 
been concerned with the binding of relatively small molecules 
to enzymes [6], or with protein-protein i teractions in natural 
oligomers, e.g. haemoglobin [7]. 
*Corresponding author. Fax: (44) (01865) 275674. 
Abbreviations: ESI MS, electrospray ionization mass spectrometry; 
BPTI, bovine pancreatic trypsin inhibitor; SBTI, soybean trypsin 
inhibitor type I-S; K15V BPTI, the site-directed mutant of BPTI in 
which Lys-15 is replaced by Val; RcamBPTI, a chemically modified 
BPTI in which the Cys-14-Cys-38 disulfide bond is reduced and the 
resultant free thiols are carboxyamidomethylated; CV, cone voltage 
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BPTI is a highly stable, basic protein consisting of a single 
polypeptide chain of 58 amino acids. The crystal structures of 
the BPTI complexes with 13-trypsin and porcine kallikrein A 
have been solved [8,9]. These have shown that the region of 
interaction, as for many proteinase inhibitors, is between the 
active site cleft of the proteinase and an external loop region 
of the BPTI. The conformational complementarity of the loop 
region and the enzyme active site and the number of interac- 
tions made between the loop and the active site of trypsin are 
responsible for the high binding energy and very low inhibi- 
tion constant, K~ =6× 10 -1'3 M [10]. This is one of the lowest 
inhibition constants observed for a non-covalent protein in- 
hibitor and for this reason it was selected as the initial target 
for analysis by ESI MS. 
BPTI can also be relatively easily modified by both chemi- 
cal and site-directed mutagenesis and in the work presented 
here, three different forms of BPTI were studied along with 
another inhibitor of trypsin, soybean trypsin inhibitor (SBTI), 
which is from a different family of proteinase inhibitors [11]. 
BPTI may be chemically modified by the reduction of a dis- 
ulfide link (C14-C38) in the exposed binding loop region [12]. 
Reduction with sodium borohydride and reaction of the free 
thiols with iodoacetamide r sults in a modified form of BPTI 
(RcamBPTI) that has different physical and inhibitory proper- 
ties e.g. Ki--1.3× 10 -9 M [10]. The primary determinant of 
specificity for BPTI, and proteinase inhibitors in general, is 
the interaction between the P1 residue of the inhibitor and the 
$1 subsite of the proteinase [13]. Site-directed mutagenesis of 
the P1 lysine to valine leads to a modified BPTI molecule 
which has totally different inhibitory properties, changing 
the specificity of inhibition from trypsin, which it no longer 
inhibits, to elastases (human leukocyte elastase-H.L.E, and 
porcine pancreatic elastase-P.P.E.) [14]. NMR data have con- 
firmed that the conformation of the loop region does not 
change significantly in this mutant and that it is the nature 
of the P1 residue that is critical to the strength of the interac- 
tion between the BPTI and trypsin. The Ki values of the in- 
hibitors (against rypsin) discussed in this paper are given in 
Table 1. The data presented here show that ESI MS can not 
only be used to detect complex formation between proteins, 
but that by analysis of the gas-phase dissociated molecular 
ions, both the strength of the interaction can be probed and 
the nature of the contact region between the two proteins 
investigated. 
2. Materials and methods 
BPTI (aprotinin) was purchased from Boehringer Mannheim. Tryp- 
sin was purchased from Sigma (T 8642; TPCK-treated, from bovine 
pancreas). SBTI type I-S was purchased from Sigma (T 6522). KI5V 
BPTI was expressed in E. coli; the production, isolation and charac- 
terisation are described elsewhere [15]. RcamBPTI was prepared ac- 
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~ording to the method of Kress and Laskowski [12]. ESI MS were 
zneasured on either a Micromass Quattro II or BioQ II mass spectro- 
meter. The following standard conditions were used: samples were 
i ffused via a Harvard Model 22 syringe pump into the electrospray 
~ource (at 3 gl/min). Analyses were performed using cone voltages of 
--40, +60 or +80 V with a source temperature of 40°C and the mass 
-pectrometer was scanned from 1000 to 4000 Da. Trypsin and inhib- 
~ors were made up in aqueous 2.5 mM ammonium acetate, pH 6.5- 
.0, and preincubated for at least 20 min at a trypsin concentration f 
0 pmol/gl. Spectra were recorded at molar inhibitor-trypsin ratios of 
:5, 1:2 and 1:1. 
L Results and discussion 
The ESI mass spectral analysis of trypsin under denaturing 
:onditions (Fig. lc) showed the expected three components A* 
I-trypsin, B* c~-trypsin and C* qLtrypsin with the typical 
~road charge state distribution from 23 + to 10 + expected 
or a denatured protein with all its residues exposed to the 
,olvent. The differences in Mr are due to partial hydrolysis (at 
K125-S126 and K170-D171) of this disulfide-linked protein 
16]. In marked contrast, analysis of trypsin from ammonium 
tcetate solution showed a simple "native state' spectrum 
Fig. la) dominated by the 10 ÷ and 9 + charge states for 
he 13-trypsin-Ca 2+ (Note: hereafter 'trypsin' will refer to the 
~-trypsin-Ca 2+complex). Analysis at increased cone voltage 
• esulted in a cleaner spectrum and some charge stripping to 
"orm the 8 +, 7 + and 6+ charge states (Fig. lb). 
ESI mass spectral analysis of the inhibitors from ammo- 
fium acetate solutions gave simple low charge state spectra 
Fig. 2a c) as anticipated for the 'native state' inhibitors. The 
differences in the charge state distributions between BPTI 
(Fig. 2a) and RcamBPTI (Fig. 2b) reflect the chemical mod- 
ification of the C14-C38 disulfide bond, the concomitant 
change in the molecule's tructure and, in particular, the ri- 
gidity of the primary (binding) and secondary loop regions. 
This allows other residues more buried in the BPTI structure 
to become protonated. 
The broad peaks observed for 'native state' SBTI (Fig. 2c) 
and the inhibitor-trypsin complexes (Fig. 3a, Figs. 4a and 5a) 
at low cone voltage (+40 V) result from incomplete desolva- 
tion of these ions prior to mass analysis. Desolvation by 
source collisional activation via increased cone voltage (+80 
V) produces sharper well defined peaks for trypsin (Fig. lb) 
and SBTI (observed M,. = 19978.5 +0.7 and a minor compo- 
nent with Mr = 20091.5 + 1.0, spectrum not shown), but leads 
to dissociation of the inhibitor-trypsin complexes (Figs. 3d 
and 5c). 
ESI mass spectral analyses of the products formed between 
trypsin and BPTI, RcamBPTI and SBTI were performed at a 
series of increasing cone voltages to evaluate the gas phase 
stability of the complexes to collisional activation. 
At cone voltages of +40 V and at a 1 : 1 molar ratio of BPTI 
to trypsin, a second series of ions series B (in addition to 
that corresponding to the native inhibitor - series C) are de- 
tected (Fig. 3a). This corresponds to a mass/charge ratio pre- 
dicted for a 1:1 complex between the trypsin and the inhibi- 
tor. This shows that the complex between trypsin and this 
slow-tight binding inhibitor is sufficiently stable for analysis 
by ESI MS, as expected from its Ki value (Table 1). 
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Fig. 1. ESI MS of trypsin: (a) native state, 10 pmol/pl, 2.5 mM NH4OAc, CV=+40 V; (b) native state, 10 pmol/lal, 2.5 mM NH4OAc, 
CV= 80 V ([~-trypsin+Ca 2÷ =23 333.4 Da); (c) denatured state, 5 pmol/gl, H20/MeCN, 1:1, 0.2% HCO2H. A=trypsin-Ca 2+complex; A*= 
I]-trypsin (Mr=23 293.3 Da), B*= c~-trypsin (Mr = 23 311.3 Da), C*= wtrypsin (Mr = 23 329.4 Da). 

















'; ~-; , j i , ,  i ~  ¸- : , 
A: 6511.1+-0.4  
A:  6626.0+-1.2  
A:  19996+-1 
A9 
i i  
J'/ 
A10 I" A8 
. . . . . . . . .  .... ,~ ,~; ,  
60 J 800 1000 1200 1400 1600 1800 2000 22,°0 2400 2600 
• " "0"~-"  - , Dale . . . .  i . . . .  i . . . .  
2800 3000 
Fig. 2. ESI MS of trypsin inhibitors, 2.5 mM NH4OAc, 10 pmol/gl: (a) BPTI (6511.5 Da), CV=+40 V; (b) RcamBPTI (6625.6 Da), CV= 
+40 V; (c) soybean trypsin inhibitor type I-S (19977.5 and 20090.7 Da), CV= +70 V. 
As a control, the mutant K15V BPTI was preincubated 
with trypsin at a ! :5, 1:2 and 1:1 molar ratio. The resultant 
spectra (Fig. 3b; only the 1:1 molar ratio shown) show only 
two series of ions, one corresponding to the K15V BPTI (se- 
ries C) and the other trypsin (series A). These series of ions 
are identical to those of the individual components run sep- 
arately, showing that non-specific binding does not occur. 
As the cone voltage is increased from +40 to +80 V, the 
spectra for the trypsin-SBTI become more clearly defined, 
with the peaks corresponding to the complex becoming shar- 
per, especially for the charges tates 11 + and 12 ÷ (Fig. 4). It is 
noteworthy that, even at the highest cone voltage (+80 V), 
there is very little dissociation of this complex to the indivi- 
dual components. 
For the trypsin complexes with the BPTI and RcamBPTI, 
the spectra are more complex. At a cone voltage of +80 V 
three series of ions are detected (Figs. 3d and 5c). Series B 
corresponds to the complex as detected at the lower cone 
voltage (+40 V; Figs. 3a and 5a, respectively) and series A 
and C correspond to the dissociated trypsin and BPTI/ 
RcamBPTI, respectively. However, the series of ions for tryp- 
sin (series A) is significantly different from that observed for 
native trypsin (Fig. l b). The series of ions has shifted to a 
lower charge state in which ions corresponding to 6 +, 7 +, 8 + 
and 9 + are identified with the dominant charge state being 7 + . 
This is clearly different from that observed for isolated trypsin 
in which ions corresponding to 6-, 7 ÷, 8 +, 9 + and 10 + are 
identified with the dominant charge state being 9 + and is in 
accord with the pH dependence of the association constant of 
BPTI for trypsin [17]. The shift in charge state distribution of 
the trypsin produced by the gas phase dissociation of the 
BPTI and RcamBPTI complex with trypsin suggests that at 
least two protonatable sites in native trypsin are masked from 
protonation in the trypsin-BPTI and trypsin-RcamBPT1 com- 
plexes. 
The significance of these results are two-fold. First, the 
detection of the protein-proteinase inhibitor complexes by 
ESI MS extends the utility of the technique to the detection 
of protein-protein non-covalent complexes. Where a protein 
exists in a variety of isoforms, it may be possible to confirm to 
which isoform(s) an inhibitor binds. In the case of trypsin, the 
results presented here suggest hat all three isoforms bind to 
the inhibitor. 
Secondly, the shift in charge state is also very significant as 
Table 1 
K~ values of trypsin-inhibitor complexes 
Inhibitor BPTI [10] RcamBPTI [9] SBTI [17,18] K15V BPTI [14] 
Ki (M) 6.0 X 10 -14 1.3 × 10 -9 1 × 10 -11 does not inhibit 
.~ A.E. Kraunsoe et a l . /FEBS Letters 396 (1996) 108 112 | l  1 
a 
i 0 '~ ~:. ".".".".".".'~'~-.~.~.-~-~",,~ "--~" ,~ . . . . . . .  ' .... , . . . . . . . . . .  
lOO~ b C5 
%1 
o ..... [ . . . . . .  IL , ,  
C ~oo C5 
C6 -! ! 
d 
C4 
' i ¸ , , i  !q~ . . . . . . . . .  , ,i 
~0%4i - 
.~x20 
C 6511 8_+02 
~x5 B: 29848_+6 
Bl l  
~ B1O 




i' ~" A8  
,~x5 C: 651 23_+0.8 
A: 23333_+2 
B: 29852_+4 
B 10 A7/B9 Bll A8 ,, 
I"1 ~.~ , ,, ~ . ~ A6  
C: 6511.9+0.1 
loo C5  ,x5 A7/B9 A: 23333+2 
C6 I ! B: 29850_+4 
LJ '~ C~ Bll A8B10 "'i A6 % 
C3 A9 !, ,,~ ~ B8 i, 
'''- . . . . .  ~'; ,i .... i ,  , i  . . . .  ; . . . .  i . . . . . . . . . .  i . . . .  = , ;  .... i , ' , ' ~ [  , i ~ ,  , , , , , , . ,  ~-~, ,  ;~., i .... i,,:,,i .... i , ,  i /e ,  
1000 1200 1400 1600 1800 2000 2200 2400 2600 2800 3000 3200 3400 3600 3800 4000 
F~ig. 3. ESI MS of trypsin plus BPTI and K15V BPTI (6482.5 Da), 2.5 mM NH4OAc, 1:1, 10 pmol/p.l: (a) trypsin+BPTI, CV=+40 V; (b) 
rypsin+Kl5V BPTI, CV = +40 V; (c) trypsin+BPTI, CV = +60 V; (d) trypsin+BPTI, CV = +80 V. A = trypsin-Ca 2+ ; B = trypsin-Ca2+-BPTI 
• omplex; C = free inhibitor. 
t gives an insight into the nature of the interaction between 
:he contact surfaces of the two proteins in the complex. The 
nature of this interaction is reflected in the charge state dis- 
tribution of the gas phase dissociated proteins, i.e. the BPTI 
leaves a 'footprint' on the trypsin. Data from the crystal struc- 
ture of the trypsin-BPTI complex and other proteinase-pro- 
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Fig. 4. ESI MS of trypsin plus soybean trypsin inhibitor type I-S, 2.5 mM NH4OAc, 1:1, l0 pmol/gl: (a) CV=+40 V; (b) CV=+60 V; 
(c) CV = +80 V. B = trypsin-Ca2+-soybean inhibitor complex. 
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Fig. 5. ES[ MS of  trypsin plus RcamBPTI, 2.5 mM NH4OAc, 1:1, 10 pmol/~tl: (a) CV = +40 V; (b) CV = +60 V; (c) CV = +80 V. A = trypsin- 
Ca 2+ ; B = trypsin-Ca2+-RcamBPTI complex; C = RcamBPTI. 
tein proteinase inhibitor complexes uggest hat 10-15 resi- 
dues of the inhibitor form close contacts with 17 29 residues 
of the proteinase. This results in 600-950 ~2 of the surface of 
each protein being buried [19]. For the trypsin-BPTI complex, 
11 residues in BPTI and 19 residues in trypsin are buried in 
the complex. Changes in the relative charge state abundance 
are observed for BPTI produced by gas phase dissociation 
(Fig. 3d) compared to that of native BPTI (Fig. 2a). RcamBP- 
TI shows a major shift to 5+/4 + (Fig. 5c) from 7+/6 + (Fig. 2b) 
when formed by gas phase dissociation of its trypsin complex. 
The change in the charge state distribution observed for 
trypsin when produced by gas phase dissociation of the inhib- 
itor complexes (Figs. 3d and 5c) may reflect a masking of 
some or all of the basic residues K176, K206 and K208 which 
are in close contact with BPTI and RcamBPTI in the com- 
plexes but are available for protonation i trypsin. Changes in 
the charge state distribution for BPTI and RcamBPTI when 
formed by gas phase dissociation suggest hat some of the 
three residues (K15, R17 and R19), which are in close contact 
with trypsin in the complexes, are involved. 
Comparision of the cone voltages at which BPTI and 
RcamBPTI dissociate from their complexes with trypsin 
(Figs. 3 and 5) suggests that ESI MS might be a useful way 
to order the strength of the binding interaction between close- 
ly related complexes, but most significantly ESI MS is a 
powerful probe for studying the ionic interactions that occur 
at the contact surface between proteins. 
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